Cidara Therapeutics, Inc.
CDTX
Ранг среди акций
#3184
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Цена акции
$221.38
Последняя синхронизация: 2026-01-08
Рыночная капитализация
$5.61B
Изменение (1 день)
0.00%
Изменение (1 год)
120.15%
Страна
US
Торговля Cidara Therapeutics, Inc. (CDTX)
Категория
Healthcare
Количество находящихся в обращении акций Cidara Therapeutics, Inc. (CDTX)
Количество акций в обращении на September 2025: 15.55M
Согласно последним финансовым отчетам и цене акций Cidara Therapeutics, Inc., текущее количество акций в обращении составляет 15.55M. На конец December 2023 у компании было 4.37M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Cidara Therapeutics, Inc. (CDTX) с 2012 по 2026
Акции в обращении на конец каждого года
| Год | Акции в обращении | Изменить |
|---|---|---|
| 2026 (TTM) | 15.55M | 144.86% |
| 2024 | 6.35M | 45.25% |
| 2023 | 4.37M | 25.15% |
| 2022 | 3.49M | 33.24% |
| 2021 | 2.62M | 26.16% |
| 2020 | 2.08M | 38.83% |
| 2019 | 1.50M | 15.71% |
| 2018 | 1.29M | 47.82% |
| 2017 | 875.04K | 20.79% |
| 2016 | 724.45K | 5.22% |
| 2015 | 688.48K | 1,579.52% |
| 2014 | 40.99K | 153.29% |
| 2013 | 16.18K | -8.65% |
| 2012 | 17.72K | 0.00% |
Акции в обращении у аналогичных компаний или конкурентов
| Компания | Акции в обращении | Разница | Страна |
|---|---|---|---|
| 253.90M | 1,533.07% |
US
|
|
| 396.00M | 2,447.05% |
US
|
|
| 478.91M | 2,980.33% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | 299.97% |
NL
|
